Clinical Trial Update: Study Evaluating Safety and Efficacy of Ropanicant in MDD Patients [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the safety and efficacy of Ropanicant in adults with Major Depressive Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Ropanicant (Ropanicant)

Snippet

Sponsor: Suven Life Sciences Limited | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED